Device Trial Radar · NCT04699708
Co2 Monitoring at Preterm Delivery-Observational Study
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
May 15, 2021
Primary completion
Feb 13, 2023
Study completion Feb 13, 2023
Sponsor
- Lead sponsor
- South Tees Hospitals NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 7, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 23 weeks, up to 32 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CO2 data, serving as a proxy marker for tidal volume, might enable titration of tidal volume/pressure thereby providing optimal ventilation during neonatal resuscitation. Currently there is insufficient data on Co2 levels for preterm babies requiring resuscitation. This study involves monitoring of CO2 during preterm stabilisation.
Conditions
- Resuscitation
Interventions
Carbon dioxide monitoringDevice
Blinded recording of CO2 during preterm resuscitation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Factors influencing carbon dioxide levels during preterm resuscitationTime frame: 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Imran Ahmed
Sunderland, United Kingdom
James Cook University Hospital
Middlesbrough, STOCKTON ON TEES, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.